Alexandra Gareau

Works (3)

Updated: April 5th, 2024 14:49

2022 article

Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma

Gareau, A., Sekiguchi, T., Warry, E., Ripoll, A. Z., Sullivan, E., Westfall, T., … Suter, S. E. (2022, July 5). Veterinary and Comparative Oncology.

By: A. Gareau n, T. Sekiguchi n, E. Warry n, A. Ripoll n, E. Sullivan*, T. Westfall *, J. Chretin*, L. Fulton* ...

author keywords: comparative oncology; hematology; oncology; small animal; stem cells
MeSH headings : Dogs; Animals; Humans; Transplantation, Homologous / veterinary; Retrospective Studies; Dog Diseases / surgery; Neoplasm Recurrence, Local / veterinary; Hematopoietic Stem Cell Transplantation / veterinary; Hematopoietic Stem Cell Transplantation / methods; Lymphoma, B-Cell / surgery; Lymphoma, B-Cell / veterinary
topics (OpenAlex): Veterinary Oncology Research; Virus-based gene therapy research; Hematopoietic Stem Cell Transplantation
TL;DR: It is suggested that allogeneic HCT can cure ~50% more dogs than those treated with autologous HCT. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: August 1, 2022

2022 article

Centrifugal therapeutic plasma exchange in dogs with immune‐mediated hemolytic anemia (2016–2018): 7 cases

Culler, C. A., Vigani, A., Ripoll, A. Z., Gareau, A., & Suter, S. E. (2022, May 2). Journal of Veterinary Emergency and Critical Care.

By: C. Culler n, A. Vigani n, A. Ripoll n, A. Gareau n & S. Suter n

author keywords: canine; IMHA; therapeutic plasma exchange
MeSH headings : Anemia, Hemolytic, Autoimmune / therapy; Anemia, Hemolytic, Autoimmune / veterinary; Animals; Anticoagulants / therapeutic use; Bilirubin; Citrates; Dog Diseases; Dogs; Humans; Immunosuppressive Agents / therapeutic use; Plasma Exchange / veterinary
topics (OpenAlex): Blood groups and transfusion; Platelet Disorders and Treatments; Blood transfusion and management
TL;DR: Retrospective review of cTPE performed at North Carolina State University from 2016 to 2018, through a search of the institutional database for cTPe and IMHA, shows it is a feasible and relatively safe bridging treatment option for the management of canine IMHA. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: May 16, 2022

2021 article

A Retrospective Analysis: Autologous Peripheral Blood Hematopoietic Stem Cell Transplant Combined With Adoptive T-Cell Therapy for the Treatment of High-Grade B-Cell Lymphoma in Ten Dogs

Gareau, A., Ripoll, A. Z., & Suter, S. E. (2021, December 7). Frontiers in Veterinary Science.

By: A. Gareau n, A. Ripoll n & S. Suter n

author keywords: adoptive T-Cell therapy; dogs; lymphoma; hematopoietic stem cell transplantation; CHOP chemotherapy
topics (OpenAlex): Virus-based gene therapy research; Veterinary Oncology Research; CAR-T cell therapy research
TL;DR: The results can only suggest that the administration of ACT to dogs after multiagent chemotherapy and autoPHSCT did not lead to a statistically significant increase in median disease-free interval and overall survival when compared to dogs who received CHOP chemotherapy and autologous peripheral blood T-cells alone. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: January 18, 2022

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.